Skip to main content
Top
Published in: Virology Journal 1/2013

Open Access 01-12-2013 | Research

H9N2 avian influenza infection altered expression pattern of Sphiogosine-1-phosphate Receptor 1 in BALB/c mice

Authors: Shuang Tong, Jin Tian, Heng Wang, Zhiqiang Huang, Meng Yu, Lingshuang Sun, Rongchang Liu, Ming Liao, Zhangyong Ning

Published in: Virology Journal | Issue 1/2013

Login to get access

Abstract

Background

The pathological damage inflicted by virulent AIV strains is often caused by inducing a positive feedback loop of cytokines in immune cells that cause excessive inflammation. Previous research has shown that a G protein-coupled receptor, sphingosine-1-phosphate receptor 1 (S1PR1), plays a crucial role in the development of excessive inflammation in influenza virus infection (Cell 146:861–862, 2011; Cell 146:980–991, 2011). BALB/c mice are common laboratory animals used in research of influenza virus; however the effects of influenza infections on expression patterns of S1PR1 in mice are unknown.

Methods

We investigated the expression patterns of S1PR1 in normal BALB/c mice and those infected by two distinct H9N2 AIV strains, one (A/chicken/Guangdong/V/2008,V) highly pathogenic, and the other (A/chicken/Guangdong/Ts/2004,Ts), non-pathogenic in mice, using quantitative PCR and immunohistochemistry (IHC) to detect S1PR1 mRNA and protein, respectively.

Results

S1PR1 mRNA was ubiquitously expressed in all the tissues examined, and significant differences were seen in mRNA expression between infected Ts, V and control mice in detected tissues, heart, liver, spleen, kidney and brain. S1PR1 protein was expressed in the cytoplasm and also demonstrated quantitative changes in expression in the various tissues between mice infected with the two strains of AIV.

Conclusions

Our results provided the first look at differences in S1PR1 expression patterns in BALB/c mice infected by non-pathogenic and highly pathogenic H9N2 influenza viruses. This information will not only be helpful in designing experiments to better understand the role of S1PR1 in virus-host interactions but also in developing novel anti-influenza agents to minimize the mortality and morbidity associated with highly virulent strains in avian and human populations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Homme PJ, Easterday BC: Avian influenza virus infections I Characteristics of influenza A-turkey-Wisconsin-1966 virus. Avian Dis 1970, 14: 66-74. 10.2307/1588557PubMedCrossRef Homme PJ, Easterday BC: Avian influenza virus infections I Characteristics of influenza A-turkey-Wisconsin-1966 virus. Avian Dis 1970, 14: 66-74. 10.2307/1588557PubMedCrossRef
2.
go back to reference Kawaoka Y, Chambers TM, Sladen WL, Webster RG: Is the gene pool of influenza viruses in shorebirds and gulls different from that in wild ducks? Virol 1988, 163: 247-250. 10.1016/0042-6822(88)90260-7CrossRef Kawaoka Y, Chambers TM, Sladen WL, Webster RG: Is the gene pool of influenza viruses in shorebirds and gulls different from that in wild ducks? Virol 1988, 163: 247-250. 10.1016/0042-6822(88)90260-7CrossRef
3.
go back to reference Bano S, Naeem K, Malik SA: Evaluation of pathogenic potential of avian influenza virus serotype H9N2 in chickens. Avian Dis 2003, 47: 817-822. 10.1637/0005-2086-47.s3.817PubMedCrossRef Bano S, Naeem K, Malik SA: Evaluation of pathogenic potential of avian influenza virus serotype H9N2 in chickens. Avian Dis 2003, 47: 817-822. 10.1637/0005-2086-47.s3.817PubMedCrossRef
4.
go back to reference Aamir UB, Wernery U, Ilyushina N, Webster RG: Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003. Virol 2007, 361: 45-55. 10.1016/j.virol.2006.10.037CrossRef Aamir UB, Wernery U, Ilyushina N, Webster RG: Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003. Virol 2007, 361: 45-55. 10.1016/j.virol.2006.10.037CrossRef
5.
go back to reference Guo YJ, Krauss S, Senne DA, Mo IP, Lo KS, Xiong XP, Norwood M, Shortridge KF, Webster RG, Guan Y: Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virol 2000, 267: 279-288. 10.1006/viro.1999.0115CrossRef Guo YJ, Krauss S, Senne DA, Mo IP, Lo KS, Xiong XP, Norwood M, Shortridge KF, Webster RG, Guan Y: Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virol 2000, 267: 279-288. 10.1006/viro.1999.0115CrossRef
6.
go back to reference Kim JA, Cho SH, Kim HS, Seo SH: H9N2 influenza viruses isolated from poultry in Korean live bird markets continuously evolve and cause the severe clinical signs in layers. Vet Microbiol 2006, 118: 169-176. 10.1016/j.vetmic.2006.07.007PubMedCrossRef Kim JA, Cho SH, Kim HS, Seo SH: H9N2 influenza viruses isolated from poultry in Korean live bird markets continuously evolve and cause the severe clinical signs in layers. Vet Microbiol 2006, 118: 169-176. 10.1016/j.vetmic.2006.07.007PubMedCrossRef
7.
go back to reference Naeem K, Ullah A, Manvell RJ, Alexander DJ: Avian influenza A subtype H9N2 in poultry in Pakistan. Vet Rec 1999, 145: 560. 10.1136/vr.145.19.560PubMedCrossRef Naeem K, Ullah A, Manvell RJ, Alexander DJ: Avian influenza A subtype H9N2 in poultry in Pakistan. Vet Rec 1999, 145: 560. 10.1136/vr.145.19.560PubMedCrossRef
8.
go back to reference Alexander DJ: A review of avian influenza in different bird species. Vet Microbiol 2000, 74: 3-13. 10.1016/S0378-1135(00)00160-7PubMedCrossRef Alexander DJ: A review of avian influenza in different bird species. Vet Microbiol 2000, 74: 3-13. 10.1016/S0378-1135(00)00160-7PubMedCrossRef
9.
go back to reference Post J, de Geus ED, Vervelde L, Cornelissen JB, Rebel J: Systemic distribution of different low pathogenic avian influenza (LPAI) viruses in chicken. Virol J 2013, 10: 23. 10.1186/1743-422X-10-23PubMedPubMedCentralCrossRef Post J, de Geus ED, Vervelde L, Cornelissen JB, Rebel J: Systemic distribution of different low pathogenic avian influenza (LPAI) viruses in chicken. Virol J 2013, 10: 23. 10.1186/1743-422X-10-23PubMedPubMedCentralCrossRef
10.
go back to reference Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge KF: Human infection with influenza H9N2. Lancet 1999, 354: 916-917. 10.1016/S0140-6736(99)03311-5PubMedCrossRef Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge KF: Human infection with influenza H9N2. Lancet 1999, 354: 916-917. 10.1016/S0140-6736(99)03311-5PubMedCrossRef
11.
go back to reference Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, et al.: Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013, 368: 1888-1897. 10.1056/NEJMoa1304459PubMedCrossRef Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, et al.: Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013, 368: 1888-1897. 10.1056/NEJMoa1304459PubMedCrossRef
12.
go back to reference Van Ranst M, Lemey P: Genesis of avian-origin H7N9 influenza A viruses. Lancet 2013, 381: 1883-1885. 10.1016/S0140-6736(13)60959-9PubMedCrossRef Van Ranst M, Lemey P: Genesis of avian-origin H7N9 influenza A viruses. Lancet 2013, 381: 1883-1885. 10.1016/S0140-6736(13)60959-9PubMedCrossRef
13.
go back to reference Sun Y, Qin K, Wang J, Pu J, Tang Q, Hu Y, Bi Y, Zhao X, Yang H, Shu Y, et al.: High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses. Proc Natl Acad Sci U S A 2011, 108: 4164-4169. 10.1073/pnas.1019109108PubMedPubMedCentralCrossRef Sun Y, Qin K, Wang J, Pu J, Tang Q, Hu Y, Bi Y, Zhao X, Yang H, Shu Y, et al.: High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses. Proc Natl Acad Sci U S A 2011, 108: 4164-4169. 10.1073/pnas.1019109108PubMedPubMedCentralCrossRef
14.
go back to reference Rosen H, Gonzalez-Cabrera PJ, Sanna MG, Brown S: Sphingosine 1-phosphate receptor signaling. Annu Rev Biochem 2009, 78: 743-768. 10.1146/annurev.biochem.78.072407.103733PubMedCrossRef Rosen H, Gonzalez-Cabrera PJ, Sanna MG, Brown S: Sphingosine 1-phosphate receptor signaling. Annu Rev Biochem 2009, 78: 743-768. 10.1146/annurev.biochem.78.072407.103733PubMedCrossRef
15.
go back to reference Rivera J, Proia RL, Olivera A: The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 2008, 8: 753-763. 10.1038/nri2400PubMedPubMedCentralCrossRef Rivera J, Proia RL, Olivera A: The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 2008, 8: 753-763. 10.1038/nri2400PubMedPubMedCentralCrossRef
16.
go back to reference Lee H, Deng J, Kujawski M, Yang C, Liu Y, Herrmann A, Kortylewski M, Horne D, Somlo G, Forman S, et al.: Stat3-induced S1PR1 expression is critical for persistent Stat3 activation in tumors. Nat Med 2010, 16: 1421-1428. 10.1038/nm.2250PubMedPubMedCentralCrossRef Lee H, Deng J, Kujawski M, Yang C, Liu Y, Herrmann A, Kortylewski M, Horne D, Somlo G, Forman S, et al.: Stat3-induced S1PR1 expression is critical for persistent Stat3 activation in tumors. Nat Med 2010, 16: 1421-1428. 10.1038/nm.2250PubMedPubMedCentralCrossRef
17.
go back to reference Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C, Shen S, Priceman SJ, Kujawski M, Pal SK, et al.: S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 2012, 21: 642-654. 10.1016/j.ccr.2012.03.039PubMedPubMedCentralCrossRef Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C, Shen S, Priceman SJ, Kujawski M, Pal SK, et al.: S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 2012, 21: 642-654. 10.1016/j.ccr.2012.03.039PubMedPubMedCentralCrossRef
18.
go back to reference Zhu D, Wang Y, Singh I, Bell RD, Deane R, Zhong Z, Sagare A, Winkler EA, Zlokovic BV: Protein S controls hypoxic/ischemic blood–brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. Blood 2010, 115: 4963-4972. 10.1182/blood-2010-01-262386PubMedPubMedCentralCrossRef Zhu D, Wang Y, Singh I, Bell RD, Deane R, Zhong Z, Sagare A, Winkler EA, Zlokovic BV: Protein S controls hypoxic/ischemic blood–brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. Blood 2010, 115: 4963-4972. 10.1182/blood-2010-01-262386PubMedPubMedCentralCrossRef
20.
go back to reference Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MB, Rosen H: Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011, 146: 980-991. 10.1016/j.cell.2011.08.015PubMedPubMedCentralCrossRef Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MB, Rosen H: Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011, 146: 980-991. 10.1016/j.cell.2011.08.015PubMedPubMedCentralCrossRef
21.
go back to reference Walsh KB, Teijaro JR, Rosen H, Oldstone MB: Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm. Immunol Res 2011, 51: 15-25. 10.1007/s12026-011-8240-zPubMedCrossRef Walsh KB, Teijaro JR, Rosen H, Oldstone MB: Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm. Immunol Res 2011, 51: 15-25. 10.1007/s12026-011-8240-zPubMedCrossRef
22.
go back to reference Tian J, Qi W, Li X, He J, Jiao P, Zhang C, Liu GQ, Liao M: A single E627K mutation in the PB2 protein of H9N2 avian influenza virus increases virulence by inducing higher glucocorticoids (GCs) level. PLoS One 2012, 7: e38233. 10.1371/journal.pone.0038233PubMedPubMedCentralCrossRef Tian J, Qi W, Li X, He J, Jiao P, Zhang C, Liu GQ, Liao M: A single E627K mutation in the PB2 protein of H9N2 avian influenza virus increases virulence by inducing higher glucocorticoids (GCs) level. PLoS One 2012, 7: e38233. 10.1371/journal.pone.0038233PubMedPubMedCentralCrossRef
23.
go back to reference Li X, Qi W, He J, Ning Z, Hu Y, Tian J, Jiao P, Xu C, Chen J, Richt J, et al.: Molecular basis of efficient replication and pathogenicity of H9N2 avian influenza viruses in mice. PLoS One 2012, 7: e40118. 10.1371/journal.pone.0040118PubMedPubMedCentralCrossRef Li X, Qi W, He J, Ning Z, Hu Y, Tian J, Jiao P, Xu C, Chen J, Richt J, et al.: Molecular basis of efficient replication and pathogenicity of H9N2 avian influenza viruses in mice. PLoS One 2012, 7: e40118. 10.1371/journal.pone.0040118PubMedPubMedCentralCrossRef
24.
go back to reference Zhang K, Zhang Z, Yu Z, Li L, Cheng K, Wang T, Huang G, Yang S, Zhao Y, Feng N, et al.: Domestic cats and dogs are susceptible to H9N2 avian influenza virus. Virus Res 2013, 175: 52-57. 10.1016/j.virusres.2013.04.004PubMedCrossRef Zhang K, Zhang Z, Yu Z, Li L, Cheng K, Wang T, Huang G, Yang S, Zhao Y, Feng N, et al.: Domestic cats and dogs are susceptible to H9N2 avian influenza virus. Virus Res 2013, 175: 52-57. 10.1016/j.virusres.2013.04.004PubMedCrossRef
25.
go back to reference Amirsalehy H, Nili H, Mohammadi A: Can dogs carry the global pandemic candidate avian influenza virus H9N2? Aust Vet J 2012, 90: 341-345. 10.1111/j.1751-0813.2012.00973.xPubMedCrossRef Amirsalehy H, Nili H, Mohammadi A: Can dogs carry the global pandemic candidate avian influenza virus H9N2? Aust Vet J 2012, 90: 341-345. 10.1111/j.1751-0813.2012.00973.xPubMedCrossRef
26.
go back to reference de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al.: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12: 1203-1207. 10.1038/nm1477PubMedPubMedCentralCrossRef de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al.: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12: 1203-1207. 10.1038/nm1477PubMedPubMedCentralCrossRef
27.
go back to reference Brinkmann V: Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 2007, 115: 84-105. 10.1016/j.pharmthera.2007.04.006PubMedCrossRef Brinkmann V: Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 2007, 115: 84-105. 10.1016/j.pharmthera.2007.04.006PubMedCrossRef
28.
go back to reference Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T: Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999, 99: 301-312. 10.1016/S0092-8674(00)81661-XPubMedCrossRef Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T: Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999, 99: 301-312. 10.1016/S0092-8674(00)81661-XPubMedCrossRef
30.
go back to reference Spiegel S, Milstien S: Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem 2002, 277: 25851-25854. 10.1074/jbc.R200007200PubMedCrossRef Spiegel S, Milstien S: Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem 2002, 277: 25851-25854. 10.1074/jbc.R200007200PubMedCrossRef
31.
go back to reference Cyster JG: Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005, 23: 127-159. 10.1146/annurev.immunol.23.021704.115628PubMedCrossRef Cyster JG: Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005, 23: 127-159. 10.1146/annurev.immunol.23.021704.115628PubMedCrossRef
32.
go back to reference Cyster JG, Schwab SR: Sphingosine-1- phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol 2012, 30: 69-94. 10.1146/annurev-immunol-020711-075011PubMedCrossRef Cyster JG, Schwab SR: Sphingosine-1- phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol 2012, 30: 69-94. 10.1146/annurev-immunol-020711-075011PubMedCrossRef
33.
go back to reference Sanchez T, Hla T: Structural and functional characteristics of S1P receptors. J Cell Biochem 2004, 92: 913-922. 10.1002/jcb.20127PubMedCrossRef Sanchez T, Hla T: Structural and functional characteristics of S1P receptors. J Cell Biochem 2004, 92: 913-922. 10.1002/jcb.20127PubMedCrossRef
34.
go back to reference Kitano M, Hla T, Sekiguchi M, Kawahito Y, Yoshimura R, Miyazawa K, Iwasaki T, Sano H, Saba JD, Tam YY: Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum 2006, 54: 742-753. 10.1002/art.21668PubMedCrossRef Kitano M, Hla T, Sekiguchi M, Kawahito Y, Yoshimura R, Miyazawa K, Iwasaki T, Sano H, Saba JD, Tam YY: Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum 2006, 54: 742-753. 10.1002/art.21668PubMedCrossRef
35.
go back to reference Wamhoff BR, Lynch KR, Macdonald TL, Owens GK: Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2008, 28: 1454-1461. 10.1161/ATVBAHA.107.159392PubMedPubMedCentralCrossRef Wamhoff BR, Lynch KR, Macdonald TL, Owens GK: Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2008, 28: 1454-1461. 10.1161/ATVBAHA.107.159392PubMedPubMedCentralCrossRef
36.
go back to reference Zhang L, Orban M, Lorenz M, Barocke V, Braun D, Urtz N, Schulz C, von Brühl ML, Tirniceriu A, Gaertner F, et al.: A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. J Exp Med 2012, 209: 2165-2181. 10.1084/jem.20121090PubMedPubMedCentralCrossRef Zhang L, Orban M, Lorenz M, Barocke V, Braun D, Urtz N, Schulz C, von Brühl ML, Tirniceriu A, Gaertner F, et al.: A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. J Exp Med 2012, 209: 2165-2181. 10.1084/jem.20121090PubMedPubMedCentralCrossRef
Metadata
Title
H9N2 avian influenza infection altered expression pattern of Sphiogosine-1-phosphate Receptor 1 in BALB/c mice
Authors
Shuang Tong
Jin Tian
Heng Wang
Zhiqiang Huang
Meng Yu
Lingshuang Sun
Rongchang Liu
Ming Liao
Zhangyong Ning
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2013
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-10-296

Other articles of this Issue 1/2013

Virology Journal 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine